RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Historical Holders from Q2 2024 to Q3 2025

Symbol
RIGL on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
16,629,429
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
14,988,939
Holdings value
$424,669,287
% of all portfolios
0.002%
Number of holders
164
Number of buys
102
Number of sells
-54
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.48% +27.7% $28,894,960 +$6,937,840 1,516,000 +31.6% Armistice Capital, LLC 31 Mar 2025
BlackRock, Inc. 7.7% -22% $26,340,596 -$6,978,323 1,381,983 -20.9% BlackRock, Inc. 31 Mar 2025
Soleus Capital Master Fund, L.P. 3.7% -45% $12,327,056 -$8,850,562 658,145 -41.8% Soleus Capital Master Fund, L.P. 30 Jun 2025
MORGAN STANLEY 0.7% $3,297,817 116,406 Morgan Stanley 30 Sep 2025
Invesco Ltd. 0% $122,918 6,449 Invesco Ltd. 31 Dec 2024

Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 14,988,939 $424,669,287 +$32,615,936 $28.33 164
2025 Q2 13,883,445 $260,032,689 +$336,299 $18.73 121
2025 Q1 13,902,025 $250,095,419 +$32,047,743 $17.99 118
2024 Q4 12,067,467 $202,977,408 +$2,514,731 $16.82 114
2024 Q3 11,904,852 $192,606,131 +$27,253,219 $16.18 87
2024 Q2 10,378,502 $85,309,593 +$85,148,446 $8.22 80